- Q1 2024 Y-mAbs Therapeutics Inc Earnings Call TranscriptMay 08, 2024$13.61 (-20.92%)Earnings
- Q4 2023 Y-mAbs Therapeutics Inc Earnings Call TranscriptMar 01, 2024$18.69 (+11.92%)Earnings
- Y-mAbs Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Y-mAbs Therapeutics Inc Earnings Call TranscriptNov 14, 2023$5.36 (+9.84%)Earnings
- Q2 2023 Y-mAbs Therapeutics Inc Earnings Call TranscriptAug 11, 2023$5.55 (-9.90%)Earnings
- Q1 2023 Y-mAbs Therapeutics Inc Earnings Call TranscriptMay 09, 2023$9.23 (+36.34%)Earnings
- Q4 2022 Y-mAbs Therapeutics Inc Earnings Call TranscriptMar 31, 2023$5.01 (+52.28%)Earnings
- Y-mAbs Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Y-mAbs Therapeutics Inc To Host Annual Research and Development Day TranscriptDec 14, 2022
- Q3 2022 Y-mAbs Therapeutics Inc Earnings Call TranscriptNov 08, 2022$3.89 (+16.12%)Earnings
- Q2 2022 Y-mAbs Therapeutics Inc Earnings Call TranscriptAug 09, 2022$17.89 (-4.33%)Earnings
- Q1 2022 Y-mAbs Therapeutics Inc Earnings Call TranscriptMay 10, 2022$10.03 (+22.02%)Earnings
- Q4 2021 Y-mAbs Therapeutics Inc Earnings Call TranscriptFeb 25, 2022$8.91 (+11.24%)Earnings
- Y-mAbs Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Y-mAbs Therapeutics Inc Research And Development Day (Virtual) TranscriptDec 15, 2021
- Q3 2021 Y-mAbs Therapeutics Inc Earnings Call TranscriptNov 05, 2021$22.23 (-6.32%)Earnings
- Y-mAbs Therapeutics Inc to Host Key Opinion Leader Webinar on DANYELZA® - Conference Call TranscriptSep 23, 2021
- Q2 2021 Y-mAbs Therapeutics Inc Earnings Call TranscriptAug 06, 2021$29.25 (-21.60%)Earnings
- Q1 2021 Y-mAbs Therapeutics Inc Earnings Call TranscriptMay 07, 2021$34.2 (+19.37%)Earnings
- Full Year 2020 Y-mAbs Therapeutics, Inc Earnings Call TranscriptFeb 26, 2021$35.17 (+4.42%)Earnings
- Y-mAbs Therapeutics, Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Y-mAbs Therapeutics, Inc. - Special Call TranscriptDec 16, 2020
- Q3 2020 Y-mAbs Therapeutics, Inc Earnings Call TranscriptNov 06, 2020$47.32 (-2.83%)Earnings
- Y-mAbs Therapeutics, Inc. - Special Call TranscriptOct 06, 2020
- Q2 2020 Y-mAbs Therapeutics, Inc Earnings Call TranscriptAug 07, 2020$38.03 (-4.33%)Earnings
- Y-mAbs Therapeutics, Inc Annual Shareholders Meeting TranscriptJun 11, 2020
- Q1 2020 Y-mAbs Therapeutics, Inc Earnings Call TranscriptMay 08, 2020$39.84 (+12.51%)Earnings
- Q4 2019 Y-mAbs Therapeutics, Inc Earnings Call TranscriptMar 12, 2020$19.66 (-14.45%)Earnings
- Y-mAbs Therapeutics, Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Y-mAbs Therapeutics, Inc. - Special Call TranscriptDec 11, 2019
- Q3 2019 Y-mAbs Therapeutics, Inc Earnings Call TranscriptNov 13, 2019$28.68 (+0.46%)Earnings
- Q2 2019 Y-mAbs Therapeutics, Inc Earnings Call TranscriptAug 14, 2019$26.16 (+1.32%)Earnings
Q2 2022 Y-mAbs Therapeutics Inc Earnings Call Transcript
Good morning, and welcome to the Y-mAbs Therapeutics, Inc.'s Earnings Conference Call for the Second Quarter 2022. Today's conference is being recorded.
Let me quickly remind you that the following discussion contains certain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Because forward-looking statements involve risks and uncertainties, they are not guarantees of future performance and actual results may differ materially from those expressed or implied by these forward-looking statements due to a variety of factors, including those risk factors discussed in the company's quarterly report on Form 10-Q for the fiscal second quarter ended June 30, 2022, as filed with the SEC on August 8, 2022.
At this time, I would like to turn the conference over to Thomas Gad, the company's Founder, Interim CEO and President. Please go ahead sir.
Thank you. Good morning, everybody,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)